Skip to main content
SpringerLink
Log in

Vitamin D in Acute and Chronic Rejection of Transplanted Kidney

  • Chapter
  • First Online:
Vitamin D in Chronic Kidney Disease

  • 872 Accesses

Abstract

Due to its nephroprotective and immunomodulatory properties, vitamin D is susceptible to have a protective role against acute and chronic renal graft rejection. Regarding acute rejection (AR), experimental studies have shown that vitamin D receptor (VDR) agonists attenuate CD4+ and CD8+ T-cell proliferation and their cytotoxic activity, decrease plasma cell differentiation, B-cell proliferation, IgG secretion and differentiation, as well as maturation and immunostimulatory capacity of dendritic cells (DCs). By limiting adaptative immune response and down-regulating DC, VDR agonists are thus susceptible to help in preventing AR. The immunomodulatory capacity of calcitriol observed in vitro has been confirmed in several animal models of transplantation without increasing the risk of infection. Some observational studies and small interventional trials in renal transplant recipients (RTR) support the potential protective role of active vitamin D against AR. Regarding chronic rejection, in addition to potentially inducing tolerogenic DCs, VDR agonists could also inhibit the production of chemokines, responsible for leukocytes infiltration in vessels allograft, and may down-regulate TGF-β pathway, which has a profibrotic activity. Other renoprotective effects of vitamin D, such as inhibition of renin angiotensin system and of NF-kB activation, may participate in the prevention of chronic allograft rejection. Although several studies have highlighted the potential nephroprotective role of vitamin D sufficiency and of VDR agonists in humans, very few studies have been performed in RTR. Three ongoing randomized controlled trials are testing native vitamin D in RTR and should help to precise the role of the vitamin D pathway in reducing (or not) the risk of acute and chronic allograft rejection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Palmer SC, McGregor DO, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 2007;(18):CD005015.

    Google Scholar 

  2. De Sevaux RG, Hoitsma AJ, Corstens FH, Wetzels JF. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol. 2002;13:1608–14.

    Article  PubMed  Google Scholar 

  3. El-Agroudy AE, El-Husseini AA, El-Sayed M, Mohsen T, Ghoneim MA. A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int. 2005;67:2039–45.

    Article  PubMed  Google Scholar 

  4. Torres A, Garcia S, Gomez A, Gonzalez A, Barrios Y, Concepcion MT, Hernandez D, Garcia JJ, Checa MD, Lorenzo V, Salido E. Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int. 2004;65:705–12.

    Article  CAS  PubMed  Google Scholar 

  5. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713–6.

    Article  CAS  PubMed  Google Scholar 

  6. Heaney RP. Vitamin D, depletion and effective calcium absorption. J Bone Miner Res. 2003;18:1342–3.

    Article  PubMed  Google Scholar 

  7. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18–28.

    CAS  PubMed  Google Scholar 

  8. Courbebaisse M, Souberbielle JC, Thervet E. Potential nonclassical effects of vitamin D in transplant recipients. Transplantation. 2010;89:131–7.

    Article  CAS  PubMed  Google Scholar 

  9. Pascussi JM, Robert A, Nguyen M, Walrant-Debray O, Garabedian M, Martin P, Pineau T, Saric J, Navarro F, Maurel P, Vilarem MJ. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest. 2005;115:177–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Juppner H, Wolf M. Post-transplant hypophosphatemia: tertiary ‘hyper-phosphatoninism’? Kidney Int. 2006;70:1486–94.

    Article  CAS  PubMed  Google Scholar 

  11. Reichrath J. Dermatologic management, sun avoidance and vitamin D status in organ transplant recipients (OTR). J Photochem Photobiol B. 2012;101:150–9.

    Article  Google Scholar 

  12. Courbebaisse M, Thervet E, Souberbielle JC, Zuber J, Eladari D, Martinez F, Mamzer-Bruneel MF, Urena P, Legendre C, Friedlander G, Prie D. Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int. 2009;75:646–51.

    Article  CAS  PubMed  Google Scholar 

  13. Wissing KM, Broeders N, Moreno-Reyes R, Gervy C, Stallenberg B, Abramowicz D. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation. 2005;79:108–15.

    Article  CAS  PubMed  Google Scholar 

  14. Benaboud S, Urien S, Thervet E, Prié D, Legendre C, Souberbielle JC, Hirt D, Friedlander G, Treluyer JM, Courbebaisse M. Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach. Eur J Clin Pharmacol. 2013;69:499–506.

    Article  CAS  PubMed  Google Scholar 

  15. Tanaci N, Karakose H, Guvener N, Tutuncu NB, Colak T, Haberal M. Influence of 1,25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study. Transplant Proc. 2003;35:2885–7.

    Article  CAS  PubMed  Google Scholar 

  16. Sezer S, Uyar M, Arat Z, Ozdemir FN, Haberal M. Potential effects of 1,25-dihydroxyvitamin D3 in renal transplant recipients. Transplant Proc. 2005;37:3109.

    Article  CAS  PubMed  Google Scholar 

  17. Lee JR, Dadhania D, August P, Lee JB, Suthanthiran M, Muthukumar T. Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients. Transplantation. 2014;98(3):292–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Obi Y, Hamano T, Ichimaru N, Tomida K, Matsui I, Fujii N, Okumi M, Kaimori JY, Yazawa K, Kokado Y, Nonomura N, Rakugi H, Takahara S, Isaka Y, Tsubakihara Y. Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study. J Clin Endocrinol Metab. 2014;99(2):527–35.

    Article  CAS  PubMed  Google Scholar 

  19. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, Jordan SC. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol. 1985;134:3032–5.

    CAS  PubMed  Google Scholar 

  20. Reichel H, Koeffler HP, Tobler A, Norman AW. 1 alpha, 25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A. 1987;84:3385–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rigby WF, Yirinec B, Oldershaw RL, Fanger MW. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur J Immunol. 1987;17:563.

    Article  CAS  PubMed  Google Scholar 

  22. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000;374:334.

    Article  CAS  PubMed  Google Scholar 

  23. Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007;179:1634–47.

    Article  CAS  PubMed  Google Scholar 

  24. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3–1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood. 2003;102:3314–6.

    Article  CAS  PubMed  Google Scholar 

  25. Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000;164:2405–11.

    Article  CAS  PubMed  Google Scholar 

  26. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A. 2001;98:6800.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chen W. The role of plasmacytoid dendritic cells in immunity and tolerance. Curr Opin Organ Transplant. 2005;10:181.

    Article  Google Scholar 

  28. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol. 2008;8:685.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lemire JM, Archer DC, Khulkarni A, Ince A, Uskokovic MR, Stepkowski S. Prolongation of the survival of murine cardiac allografts by the vitamin D3 analogue 1,25-dihydroxy-delta 16-cholecalciferol. Transplantation. 1992;54:762–3.

    Article  CAS  PubMed  Google Scholar 

  30. Zhang AB, Zheng SS, Jia CK, Wang Y. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol. 2003;9:1067.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Casteels K, Waer M, Laureys J, Valckx D, Depovere J, Bouillon R, Mathieu C. Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. Transplantation. 1998;65:1225–32.

    Article  CAS  PubMed  Google Scholar 

  32. Kallio E, Häyry P, Pakkala S. MC1288, a vitamin D analogue, reduces short- and long-term renal allograft rejection in the rat. Transplant Proc. 1996;28(6):3113.

    CAS  PubMed  Google Scholar 

  33. Cantorna MT, Hullett DA, Redaelli C, Brandt CR, Humpal-Winter J, Sollinger HW, Deluca HF. 1,25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density. Transplantation. 1998;66:828.

    Article  CAS  PubMed  Google Scholar 

  34. Ardalan MR, Maljaei H, Shoja MM, Piri AR, Khosroshahi HT, Noshad H, Argani H. Calcitriol started in the donor, expands the population of CD4+CD25+ T cells in renal transplant recipients. Transplant Proc. 2007;39:951–3.

    Article  CAS  PubMed  Google Scholar 

  35. Ahmadpoor P, Ilkhanizadeh B, Ghasemmahdi L, Makhdoomi K, Ghafari A. Effect of active vitamin D on expression of co-stimulatory molecules and HLA-DR in renal transplant recipients. Exp Clin Transplant. 2009;7:99–103.

    PubMed  Google Scholar 

  36. van Etten E, Mathieu C. Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97:93.

    Article  PubMed  Google Scholar 

  37. Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005;68:2823–8.

    Article  CAS  PubMed  Google Scholar 

  38. Lee DR, Kong JM, Cho KI, Chan L. Impact of vitamin D on proteinuria, insulin resistance, and cardiovascular parameters in kidney transplant recipients. Transplant Proc. 2011;43(10):3723–9.

    Article  CAS  PubMed  Google Scholar 

  39. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007;50:69–77.

    Article  PubMed  Google Scholar 

  40. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009;75:88.

    Article  CAS  PubMed  Google Scholar 

  41. O’Herrin JK, Hullett DA, Heisey DM, Sollinger HW, Becker BN. A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function. Am J Nephrol. 2002;22:515–20.

    Article  PubMed  Google Scholar 

  42. Vu D, Sakharkar P, Tellez-Corrales E, Shah T, Hutchinson I, Min DI. Association of vitamin D binding protein polymorphism with long-term kidney allograft survival in hispanic kidney transplant recipients. Mol Biol Rep. 2013;40(2):933–9.

    Article  CAS  PubMed  Google Scholar 

  43. Lavin PJ, Laing ME, O’Kelly P, Moloney FJ, Gopinathan D, Aradi AA, Shields DC, Murphy GM, Conlon PJ. Improved renal allograft survival with vitamin D receptor polymorphism. Ren Fail. 2007;29(7):785–9.

    Article  CAS  PubMed  Google Scholar 

  44. Adorini L, Amuchastegui S, Daniel KC. Prevention of chronic allograft rejection by vitamin D receptor agonists. Immunol Lett. 2005;100:34–41.

    Article  CAS  PubMed  Google Scholar 

  45. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med. 2004;116:263.

    Article  CAS  PubMed  Google Scholar 

  46. Sun J, Kong J, Duan Y, Szeto FL, Liao A, Madara JL, Li YC. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab. 2006;291:E315.

    Article  CAS  PubMed  Google Scholar 

  47. Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol. 2006;17:3382.

    Article  CAS  PubMed  Google Scholar 

  48. Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E. Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 1998;53:1696.

    Article  CAS  PubMed  Google Scholar 

  49. Kuhlmann A, Haas CS, Gross ML, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol. 2004;286:F526.

    Article  CAS  PubMed  Google Scholar 

  50. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, Li YC, Rodriguez-Iturbe B. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int. 2008;74:1394–402.

    Article  CAS  PubMed  Google Scholar 

  51. Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, Quigg RJ, Li YC. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Kidney Int. 2008;73:163.

    Article  CAS  PubMed  Google Scholar 

  52. Park JW, Bae EH, Kim IJ, Ma SK, Choi C, Lee J, Kim SW. Paricalcitol attenuates cyclosporine-induced kidney injury in rats. Kidney Int. 2010;77(12):1076–85.

    Article  CAS  PubMed  Google Scholar 

  53. Hullett DA, Laeseke PF, Malin G, Nessel R, Sollinger HW, Becker BN. Prevention of chronic allograft nephropathy with vitamin D. Transpl Int. 2005;18:1175–86.

    Article  PubMed  Google Scholar 

  54. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376(9752):1543–51.

    Article  PubMed  Google Scholar 

  55. Courbebaisse M, Xu-Dubois YC, Thervet E, Prié D, Zuber J, Kreis H, Legendre C, Rondeau E, Pallet N. Cholecalciferol supplementation does not protect against renal allograft structural and functional deterioration: a retrospective study. Transplantation. 2011;91(2):207–12.

    Article  PubMed  Google Scholar 

  56. Courbebaisse M, Alberti C, Colas S, Prié D, Souberbielle JC, Treluyer JM, Thervet E. VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,000 UI in renal transplant recipients: study protocol for a double-blind, randomized, controlled trial. Trials. 2014;15:430.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Thiem U, Heinze G, Segel R, Perkmann T, Kainberger F, Mühlbacher F, Hörl W, Borchhardt K. VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome. Trials. 2009;10:36.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Functional Renal Explorations Service, Department of Physiology, Georges Pompidou European Hospital, Paris, France

    Marie Courbebaisse MD, PhD

Authors
  1. Marie Courbebaisse MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marie Courbebaisse MD, PhD .

Editor information

Editors and Affiliations

  1. Ramsay-Générale de Santé, Clinique du Landy, Saint Ouen, France

    Pablo A. Ureña Torres

  2. San Paolo Hospital, DiSS University of Milan, Milan, Italy

    Mario Cozzolino

  3. VU University Medical Center, Amsterdam, The Netherlands

    Marc G. Vervloet

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Courbebaisse, M. (2016). Vitamin D in Acute and Chronic Rejection of Transplanted Kidney. In: Ureña Torres, P., Cozzolino, M., Vervloet, M. (eds) Vitamin D in Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-32507-1_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-32507-1_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-32505-7

  • Online ISBN: 978-3-319-32507-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation